Back to search
FDAFDA · Food and drugs·Recall number Z-1578-2022

Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Dark Blue: a) 25 pack REF H938693025, b) 100 pack REF H938673100

Published August 31, 2022 · Recall initiated: July 22, 2022

Summary

FDA records medical device Class II recall Z-1578-2022, published August 31, 2022 and initiated July 22, 2022. Recalling firm: Baxter Healthcare Corporation; Status: Ongoing; Reported quantity: 24,320 units; Lot: a) 25 pack REF H938693025, UDI 00085412479965, ALL LOTS; b) 100 pack REF H938673100, UDI 00085412479798, ALL LOTS. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Baxter Healthcare Corporation
Distributor
Worldwide distribution: US (nationwide) distribution and OUS (foreign) : Australia, Finland, Germany, Spain and United Kingdom.
Lot
a) 25 pack REF H938693025, UDI 00085412479965, ALL LOTS; b) 100 pack REF H938673100, UDI 00085412479798, ALL LOTS
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Baxter DISCPAC Syringe Tip Caps, Self-Righting, Luer Slip, Dark Blue: a) 25 pack REF H938693025, b) 100 pack REF H938673100 recalled?

Yes. FDA published recall Z-1578-2022 on August 31, 2022. Reported hazard: There is a potential of the packaging not maintaining a sterile barrier for the tip caps.

What should I do if I have this product?

Voluntary: Firm initiated · Letter